Factors influencing the prescribing of medications by old age psychiatrists for behavioural and psychological symptoms of dementia: a qualitative study

被引:58
作者
Wood-Mitchell, Amy [1 ]
James, Ian Andrew [1 ,2 ]
Waterworth, Anna [1 ]
Swann, Alan [1 ]
Ballard, Clive [3 ]
机构
[1] Northumberland Tyne & Wear NHS Trust, Northumberland, England
[2] Clin Psychol Serv Older People, N Tyneside & Northumberland Mental Hlth NHS Trust, Newcastle Upon Tyne, Tyne & Wear, England
[3] Kings Coll London, Inst Psychiat, London WC2R 2LS, England
关键词
neuroleptics; antipsychotics; challenging behaviour; care homes; qualitative;
D O I
10.1093/ageing/afn135
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background: despite evidence of limited efficacy, psychotropic medications are widely used as a first line treatment for those with behavioural and psychological symptoms of dementia (BPSD). Clearly various factors must be influencing their continued use; these are explored here. Aims: to examine the process by which consultant old age psychiatrists prescribe for BPSD and explore the factors that influence their decisions. Method: a focus group generated initial questions for interviews with eight consultant old age psychiatrists, using a grounded theory methodology. Results: differences in how assessment information was utilised resulted in inconsistencies in choice of medication between psychiatrists. Psychiatrists felt pressured to prescribe, largely due to resource issues and lack of viable alternative treatments. Conclusion: the ways in which psychiatrists prescribe for BPSD varies amongst clinicians. Guidelines do exist, but are difficult to implement in practice. Alternative non-pharmacological strategies are required, but as yet they are difficult to access and have a questionable evidence base.
引用
收藏
页码:547 / 552
页数:6
相关论文
共 16 条
[1]  
[Anonymous], 1998, TECHNIQUES PROCEDURE
[2]   The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease [J].
Ballard, C ;
Waite, J .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (01)
[3]   Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial [J].
Ballard, C ;
Margallo-Lana, M ;
Juszczak, E ;
Douglas, S ;
Swann, A ;
Thomas, A ;
O'Brien, J ;
Everratt, A ;
Sadler, S ;
Maddison, C ;
Lee, L ;
Bannister, C ;
Elvish, R ;
Jacoby, R .
BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7496) :874-877
[4]   Neuroleptic drugs in dementia: benefits and harm [J].
Ballard, Clive ;
Howard, Robert .
NATURE REVIEWS NEUROSCIENCE, 2006, 7 (06) :492-500
[5]  
*COMM SAF MED, 2004, AT ANT DRUGS STROK
[6]   Psychotropic prescribing for older people in residential care in the UK, are guidelines being followed? [J].
Dempsey, OP ;
Moore, H .
PRIMARY CARE & COMMUNITY PSYCHIATRY, 2005, 10 (01) :13-18
[7]  
*FDA, 2005, FDA ISS PUBL HLTH AD
[8]   Guidelines for the management of agitation in dementia [J].
Howard, R ;
Ballard, C ;
O'Brien, J ;
Burns, A .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2001, 16 (07) :714-717
[9]   Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up [J].
McShane, R ;
Keene, J ;
Gedling, K ;
Fairburn, C ;
Jacoby, R ;
Hope, T .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 314 (7076) :266-270
[10]  
*NAT I HLTH CLIN E, 2006, 42 NICE